Inotrem is a biotechnology company specialized in immunotherapy for acute inflammatory syndromes, such as septic shock.
Inotrem's investors include Bpifrance, Andera Partners, Sofinnova Partners, Invus, BioMedPartners.
Inotrem is headquartered in Paris, France.
Inotrem is a biotechnology company specialized in immunotherapy for acute inflammatory syndromes, such as septic shock.
Inotrem is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Inotrem — Funding & Investors." VCBacked, November 6, 2023, https://www.vcbacked.co/company/inotrem. Accessed July 20, 2026.
VCBacked. (2023). Inotrem — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/inotrem
{{cite web |title=Inotrem — Funding & Investors |url=https://www.vcbacked.co/company/inotrem |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated